128 related articles for article (PubMed ID: 35544467)
1. Correlation of the transcription factors
Zhang Y; Zeng X; Zha X; Lai J; Tan G; Chen S; Yu X; Li Y; Xu L
Hematology; 2022 Dec; 27(1):523-529. PubMed ID: 35544467
[TBL] [Abstract][Full Text] [Related]
2. Expression of interferon regulatory factor 4 in chronic myeloid leukemia: correlation with response to interferon alfa therapy.
Schmidt M; Hochhaus A; König-Merediz SA; Brendel C; Proba J; Hoppe GJ; Wittig B; Ehninger G; Hehlmann R; Neubauer A
J Clin Oncol; 2000 Oct; 18(19):3331-8. PubMed ID: 11013272
[TBL] [Abstract][Full Text] [Related]
3. Transcription factor BACH2 is transcriptionally regulated by the BCR/ABL oncogene.
Vieira SA; Deininger MW; Sorour A; Sinclair P; Foroni L; Goldman JM; Melo JV
Genes Chromosomes Cancer; 2001 Dec; 32(4):353-63. PubMed ID: 11746976
[TBL] [Abstract][Full Text] [Related]
4. Bach2 overexpression represses Th9 cell differentiation by suppressing IRF4 expression in systemic lupus erythematosus.
Sheng Y; Zhang J; Li K; Wang H; Wang W; Wen L; Gao J; Tang X; Tang H; Huang H; Cai M; Yuan T; Liu L; Zheng X; Zhu Z; Cui Y
FEBS Open Bio; 2021 Feb; 11(2):395-403. PubMed ID: 33249782
[TBL] [Abstract][Full Text] [Related]
5. Age-related changes in the BACH2 and PRDM1 genes in lymphocytes from healthy donors and chronic lymphocytic leukemia patients.
Chi VLD; Garaud S; De Silva P; Thibaud V; Stamatopoulos B; Berehad M; Gu-Trantien C; Krayem M; Duvillier H; Lodewyckx JN; Willard-Gallo K; Sibille C; Bron D
BMC Cancer; 2019 Jan; 19(1):81. PubMed ID: 30654767
[TBL] [Abstract][Full Text] [Related]
6. Bcr-Abl signaling through the PI-3/S6 kinase pathway inhibits nuclear translocation of the transcription factor Bach2, which represses the antiapoptotic factor heme oxygenase-1.
Yoshida C; Yoshida F; Sears DE; Hart SM; Ikebe D; Muto A; Basu S; Igarashi K; Melo JV
Blood; 2007 Feb; 109(3):1211-9. PubMed ID: 17018862
[TBL] [Abstract][Full Text] [Related]
7. Interferon regulatory factor 4 plays a pivotal role in the development of aGVHD-associated colitis.
Frueh JT; Campe J; Sunaga-Franze DY; Verheyden NA; Ghimire S; Meedt E; Haslinger D; Harenkamp S; Staudenraus D; Sauer S; Kreft A; Schubert R; Lohoff M; Krueger A; Bonig H; Chiocchetti AG; Zeiser R; Holler E; Ullrich E
Oncoimmunology; 2024; 13(1):2296712. PubMed ID: 38170159
[TBL] [Abstract][Full Text] [Related]
8. Bioinformatics analysis and identification of hub genes and immune-related molecular mechanisms in chronic myeloid leukemia.
Yao F; Zhao C; Zhong F; Qin T; Li S; Liu J; Huang B; Wang X
PeerJ; 2022; 10():e12616. PubMed ID: 35111390
[TBL] [Abstract][Full Text] [Related]
9. Transcription Factor IRF4 Promotes CD8
Man K; Gabriel SS; Liao Y; Gloury R; Preston S; Henstridge DC; Pellegrini M; Zehn D; Berberich-Siebelt F; Febbraio MA; Shi W; Kallies A
Immunity; 2017 Dec; 47(6):1129-1141.e5. PubMed ID: 29246443
[TBL] [Abstract][Full Text] [Related]
10. Regulation of the interferon regulatory factor-8 (IRF-8) tumor suppressor gene by the signal transducer and activator of transcription 5 (STAT5) transcription factor in chronic myeloid leukemia.
Waight JD; Banik D; Griffiths EA; Nemeth MJ; Abrams SI
J Biol Chem; 2014 May; 289(22):15642-52. PubMed ID: 24753251
[TBL] [Abstract][Full Text] [Related]
11. Accelerated plasma-cell differentiation in Bach2-deficient mouse B cells is caused by altered IRF4 functions.
Ochiai K; Shima H; Tamahara T; Sugie N; Funayama R; Nakayama K; Kurosaki T; Igarashi K
EMBO J; 2024 May; 43(10):1947-1964. PubMed ID: 38605225
[TBL] [Abstract][Full Text] [Related]
12. Attenuation of TCR-induced transcription by Bach2 controls regulatory T cell differentiation and homeostasis.
Sidwell T; Liao Y; Garnham AL; Vasanthakumar A; Gloury R; Blume J; Teh PP; Chisanga D; Thelemann C; de Labastida Rivera F; Engwerda CR; Corcoran L; Kometani K; Kurosaki T; Smyth GK; Shi W; Kallies A
Nat Commun; 2020 Jan; 11(1):252. PubMed ID: 31937752
[TBL] [Abstract][Full Text] [Related]
13. [Change of expression pattern of CD3 genes in peripheral blood T-cells from CML patients].
Yang LJ; Chen SH; Wang L; Chen S; Yu Z; Lu YH; Li YQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Aug; 18(4):937-41. PubMed ID: 20723304
[TBL] [Abstract][Full Text] [Related]
14. IRF4 Gene Expression on the Trail of Molecular Response: Looking at Chronic Myeloid Leukemia from Another Perspective.
Tarantini F; Cumbo C; Parciante E; Anelli L; Zagaria A; Coccaro N; Minervini CF; Tota G; Redavid I; Conserva MR; Attolico I; Rossi AR; Specchia G; Musto P; Albano F
Acta Haematol; 2023; 146(1):37-43. PubMed ID: 36195064
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of the TCR Vβ repertoire in imatinib-resistant chronic myeloid leukemia patients with ABL mutations.
Xu L; Lu Y; Lai J; Yu W; Zhang Y; Jin Z; Xu Y; Chen J; Zha X; Chen S; Yang L; Li Y
Sci China Life Sci; 2015 Dec; 58(12):1276-81. PubMed ID: 26423566
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional suppression of BACH2 by the Bcr-Abl oncoprotein is mediated by PAX5.
Casolari DA; Makri M; Yoshida C; Muto A; Igarashi K; Melo JV
Leukemia; 2013 Feb; 27(2):409-15. PubMed ID: 22858985
[TBL] [Abstract][Full Text] [Related]
17. Nuclear positioning of the BACH2 gene in BCR-ABL positive leukemic cells.
Ono A; Kono K; Ikebe D; Muto A; Sun J; Kobayashi M; Ueda K; Melo JV; Igarashi K; Tashiro S
Genes Chromosomes Cancer; 2007 Jan; 46(1):67-74. PubMed ID: 17044046
[TBL] [Abstract][Full Text] [Related]
18. Identification of key candidate targets and pathways for the targeted treatment of leukemia stem cells of chronic myelogenous leukemia using bioinformatics analysis.
Li H; Liu L; Zhuang J; Liu C; Zhou C; Yang J; Gao C; Liu G; Sun C
Mol Genet Genomic Med; 2019 Sep; 7(9):e851. PubMed ID: 31373443
[TBL] [Abstract][Full Text] [Related]
19. Shared and distinct functions of the transcription factors IRF4 and IRF8 in myeloid cell development.
Yamamoto M; Kato T; Hotta C; Nishiyama A; Kurotaki D; Yoshinari M; Takami M; Ichino M; Nakazawa M; Matsuyama T; Kamijo R; Kitagawa S; Ozato K; Tamura T
PLoS One; 2011; 6(10):e25812. PubMed ID: 22003407
[TBL] [Abstract][Full Text] [Related]
20. Identification and validation of hub genes and molecular classifications associated with chronic myeloid leukemia.
Zhong F; Yao F; Xu S; Zhang J; Liu J; Wang X
Front Immunol; 2023; 14():1297886. PubMed ID: 38283355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
